Clinical trial

The RESPOND Outcomes Study

NCT04090151

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2017-01-01

PhaseN/A

Study timeline

Study start (actual)2017-01-01Date precision: day

Registry last updated2024-04-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIVunresolved

Interventions

Sponsors & collaborators

Copenhagen University Hospital, Rigshospitaletlead sponsor

Gilead Sciencescollaborator

ViiV Healthcarecollaborator

Mapped research locations

MilanItaly2 CopenhagenDenmark2 LondonUnited Kingdom1 BrusselsBelgium1 AmsterdamNetherlands1 StockholmSweden1 NiceFrance1 CologneGermany1 FrankfurtGermany1 ZurichSwitzerland1 BonnGermany1 SydneyNew South Wales, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04090151 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.